173 related articles for article (PubMed ID: 22847457)
1. Effect of repeated treatment with topiramate on voluntary alcohol intake and beta-endorphin plasma level in Warsaw alcohol high-preferring rats.
Zalewska-Kaszubska J; Bajer B; Gorska D; Andrzejczak D; Dyr W; Bieńkowski P
Psychopharmacology (Berl); 2013 Jan; 225(2):275-81. PubMed ID: 22847457
[TBL] [Abstract][Full Text] [Related]
2. Voluntary alcohol consumption and plasma beta-endorphin levels in alcohol preferring rats chronically treated with levetiracetam: a preliminary study.
Zalewska-Kaszubska J; Bajer B; Czarnecka E; Dyr W; Gorska D
Physiol Behav; 2011 Mar; 102(5):538-41. PubMed ID: 21187108
[TBL] [Abstract][Full Text] [Related]
3. Effect of repeated treatment with topiramate on the beta-endorphin plasma level in rats selectively bred for high and low alcohol preference.
Zalewska-Kaszubska J; Gorska D; Dyr W; Czarnecka E
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):525-8. PubMed ID: 17215064
[TBL] [Abstract][Full Text] [Related]
4. Voluntary alcohol consumption and plasma beta-endorphin levels in alcohol preferring rats chronically treated with lamotrigine.
Zalewska-Kaszubska J; Bajer B; Gorska D; Andrzejczak D; Dyr W; Bieńkowski P
Physiol Behav; 2015 Feb; 139():7-12. PubMed ID: 25449391
[TBL] [Abstract][Full Text] [Related]
5. Voluntary alcohol consumption and plasma beta-endorphin levels in alcohol-preferring rats chronically treated with naltrexone.
Zalewska-Kaszubska J; Gorska D; Dyr W; Czarnecka E
Physiol Behav; 2008 Mar; 93(4-5):1005-10. PubMed ID: 18262210
[TBL] [Abstract][Full Text] [Related]
6. Effect of chronic acamprosate treatment on voluntary alcohol intake and beta-endorphin plasma levels in rats selectively bred for high alcohol preference.
Zalewska-Kaszubska J; Górska D; Dyr W; Czarnecka E
Neurosci Lett; 2008 Feb; 431(3):221-5. PubMed ID: 18162308
[TBL] [Abstract][Full Text] [Related]
7. Severity of drinking as a predictor of efficacy of the combination of ondansetron and topiramate in rat models of ethanol consumption and relapse.
Lynch WJ; Bond C; Breslin FJ; Johnson BA
Psychopharmacology (Berl); 2011 Sep; 217(1):3-12. PubMed ID: 21424693
[TBL] [Abstract][Full Text] [Related]
8. Effect of topiramate treatment on ethanol consumption in rats.
Breslin FJ; Johnson BA; Lynch WJ
Psychopharmacology (Berl); 2010 Jan; 207(4):529-34. PubMed ID: 19823810
[TBL] [Abstract][Full Text] [Related]
9. Effect of acute administration of ethanol on beta-endorphin plasma level in ethanol preferring and non-preferring rats chronically treated with naltrexone.
Zalewska-Kaszubska J; Gorska D; Dyr W; Czarnecka E
Pharmacol Biochem Behav; 2006 Sep; 85(1):155-9. PubMed ID: 16934320
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of a low dose combination of topiramate and naltrexone on ethanol reinforcement and consumption in rat models.
Moore CF; Protzuk OA; Johnson BA; Lynch WJ
Pharmacol Biochem Behav; 2014 Jan; 116():107-15. PubMed ID: 24252444
[TBL] [Abstract][Full Text] [Related]
11. Changes in the beta-endorphin plasma level after repeated treatment with acamprosate in rats selectively bred for high and low alcohol preference.
Zalewska-Kaszubska J; Cwiek W; Dyr W; Czarnecka E
Neurosci Lett; 2005 Nov; 388(1):45-8. PubMed ID: 16009491
[TBL] [Abstract][Full Text] [Related]
12. Effects of topiramate on ethanol and saccharin consumption and preferences in C57BL/6J mice.
Gabriel KI; Cunningham CL
Alcohol Clin Exp Res; 2005 Jan; 29(1):75-80. PubMed ID: 15654294
[TBL] [Abstract][Full Text] [Related]
13. Lack of changes in beta-endorphin plasma levels after repeated treatment with fluoxetine: possible implications for the treatment of alcoholism--a pilot study.
Zalewska-Kaszubska J; Górska D; Dyr W; Czarnecka E
Pharmazie; 2008 Apr; 63(4):308-11. PubMed ID: 18468392
[TBL] [Abstract][Full Text] [Related]
14. Zonisamide decreases ethanol intake in rats and mice.
Knapp CM; Mercado M; Markley TL; Crosby S; Ciraulo DA; Kornetsky C
Pharmacol Biochem Behav; 2007 May; 87(1):65-72. PubMed ID: 17482246
[TBL] [Abstract][Full Text] [Related]
15. Effects of acute ethanol on beta-endorphin release in the nucleus accumbens of selectively bred lines of alcohol-preferring AA and alcohol-avoiding ANA rats.
Lam MP; Nurmi H; Rouvinen N; Kiianmaa K; Gianoulakis C
Psychopharmacology (Berl); 2010 Jan; 208(1):121-30. PubMed ID: 19940981
[TBL] [Abstract][Full Text] [Related]
16. Carisbamate, a novel antiepileptic candidate compound, attenuates alcohol intake in alcohol-preferring rats.
Rezvani AH; Overstreet DH; Vaidya AH; Zhao B; Levin ED
Alcohol Clin Exp Res; 2009 Aug; 33(8):1366-73. PubMed ID: 19413647
[TBL] [Abstract][Full Text] [Related]
17. Acute and chronic administration of a low-dose combination of topiramate and ondansetron reduces ethanol's reinforcing effects in male alcohol preferring (P) rats.
Moore CF; Lycas MD; Bond CW; Johnson BA; Lynch WJ
Exp Clin Psychopharmacol; 2014 Feb; 22(1):35-42. PubMed ID: 24490709
[TBL] [Abstract][Full Text] [Related]
18. Review of topiramate: an antiepileptic for the treatment of alcohol dependence.
Kenna GA; Lomastro TL; Schiesl A; Leggio L; Swift RM
Curr Drug Abuse Rev; 2009 May; 2(2):135-42. PubMed ID: 19630744
[TBL] [Abstract][Full Text] [Related]
19. Effects of treatment with acamprosate on beta-endorphin plasma concentration in humans with high alcohol preference.
Kiefer F; Jahn H; Otte C; Nakovics H; Wiedemann K
Neurosci Lett; 2006 Aug; 404(1-2):103-6. PubMed ID: 16782270
[TBL] [Abstract][Full Text] [Related]
20. Oral topiramate reduces the consequences of drinking and improves the quality of life of alcohol-dependent individuals: a randomized controlled trial.
Johnson BA; Ait-Daoud N; Akhtar FZ; Ma JZ
Arch Gen Psychiatry; 2004 Sep; 61(9):905-12. PubMed ID: 15351769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
